Intellia Therapeutics
NTLA
$21.57
Share price
1.17%
Change (1 day)
-42.56%
Change (1 year)
Operating Margin for Intellia Therapeutics (NTLA)
Operating Margin as of April 2024 (TTM): -854.92%
According to Intellia Therapeutics's latest financial reports and stock price the company's current Operating Margin is -854.92%. At the end of 2022 the company had an Operating Margin of -909.78%.
Operating Margin history for Intellia Therapeutics from 2015 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | -909.78% | 12.25% |
| 2021 | -810.49% | 250.17% |
| 2020 | -231.46% | 0.23% |
| 2019 | -230.92% | -17.65% |
| 2018 | -280.42% | 8.43% |
| 2017 | -258.62% | 34.72% |
| 2016 | -191.97% | -13.47% |
| 2015 | -221.86% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 0.00% | N/A | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.